Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Alternative Response Criteria (Choi, European Association for the Study of the Liver, and Modified Response Evaluation Criteria in Solid Tumors [RECIST]) Versus RECIST 1.1 in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib
PaperCitations, authors & open-access status
Alternative Response Criteria (Choi, European Association for the Study of the Liver, and Modified Response Evaluation Criteria in Solid Tumors [RECIST]) Versus RECIST 1.1 in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 157 citations, 2014 year and bronze oa status.
157
Citations
2014
Year
bronze
OA Status